Study models how clinicians think about managing drug-drug interactions
Editor's Note A study published in BMJ Open is “the first to present an illustrative model of clinicians’ real-world decision making for managing DDIs,” the outlet reported on December 1. DDIs, or drug-drug interactions, are known to cause significant harm (including death), hundreds of thousands of patients hospitalized each year…
Drug shortages are getting worse nationwide
Editor's Note Across the US, drug shortages are on the rise, including for chemotherapy drugs, antibiotics, and weight-loss drugs, PBS News November 5 reports. This trend is worrisome for many reasons, experts say, with the top-pressing concern being high-risk patients having to switch to less effective or more aggressive regimens…
Scientists are training AI to predict drug interactions
Editor's Note An international team of scientists designed an artificial intelligence (AI) platform to provide insights into how a particular drug will interact in an individual prior to administration, Science Direct October 31 reports. The findings were published in the journal Cell Reports. Among the findings: One-third of drugs work…
Antibiotic resistance creating global health threat for children
Editor's Note Widespread antibiotic resistance globally has meant that drugs used to treat common infections in children and babies are no longer effective, according to a new study published on October 31 by Science Direct. The study found that a number of antibiotics recommended by the World Health Organization (WHO)…
National prescription drug 'Take Back Day' is October 28
The Federal Drug Enforcement Administration (DEA) has announced that the National Prescription Drug 'Take Back Day' is this Saturday, October 28. The day allows the public to dispose safely of prescription drugs. On that day, the public is invited to dispose of unneeded medications at almost 5,000 local drop-off locations nationwide,…
New agreement between HHS, Pfizer to ensure access to Paxlovid
Editor's Note The US Department of Health and Human Services (HHS) and Pfizer have announced an agreement to extend patient access to the COVID-19 drug Paxlovid, Healthcare Purchasing News October 16 reports. According to the article, Pfizer is readying the drug for more availability in the commercial market in November…
Limiting opioid medication did not negatively impact patients post-surgery
Editor's Note A 5-day limit on opioid pain medication prescriptions in Michigan did not negatively impact patient-reported pain levels or satisfaction, JAMA Network October 13 reports. The study, titled "Changes in surgical opioid prescribing and patient-reported outcomes after implementation of an insurer opioid prescribing limit," was published by JAMA Health…
The Joint Commission updates requirements for medication compounding
Editor's Note The Joint Commission, on July 19, announced that it has revised its Medication Compounding (MC) chapter for home care organizations and the Medication Compounding Certification (MDC) program, which is available to accredited hospitals, critical access hospitals, and home care pharmacy organizations. Among the revisions: Revising the requirements to…
Unintentional drug overdoses spiked in adolescents during COVID-19
Editor's Note This study by researchers at The Ohio State University Wexner Medical Center and College of Medicine, Columbus, finds that the first year of COVID-19 saw a 113% increase in “Years of Life Lost” (YLL) among adolescents and young people in the US because of unintentional drug overdoses. Among…
FDA: Class I recall of Baxter Clearlink Basic Solution Set with Duovent
Editor's Note The Food and Drug Administration (FDA) on September 15 identified Baxter Healthcare Corporation’s recall of its ClearLink Basic Solution Set with Duovent as Class I, the most serious. The recall was initiated because of the risk for leaks that may expose providers and patients to hazardous toxic substances…
Free Daily News
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
- CMS final rule for CY 2025: Key updates impacting Medicare payments, quality programs
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity
- Study finds high rates of preventable, adverse events in perioperative care
- AMA urges stronger radiation protections
- Study: Digital tool detects preoperative pediatric anxiety, depression